<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01855542</url>
  </required_header>
  <id_info>
    <org_study_id>4-2012-0059</org_study_id>
    <nct_id>NCT01855542</nct_id>
  </id_info>
  <brief_title>The Aim of This Investigation is to Compare the Influence of 0.9% Saline and Plasmalyte Solution on Acid-base Balance and Electrolytes in Healthy Patients Undergoing Major Spine Surgeries.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chloride-rich isotonic crystalloid solutions have been shown to exert electrolyte imbalance
      and metabolic acidosis in critically ill patients. The aim of this investigation is to
      compare the influence of 0.9% saline and plasmalyte solution on acid-base balance and
      electrolytes in healthy patients undergoing major spine surgeries.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>base-excess</measure>
    <time_frame>Change from baseline in base-excess at postoperative 12 h</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Spinal Surgery</condition>
  <arm_group>
    <arm_group_label>0.9% saline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>plasmalyte</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>0.9% normal saline</intervention_name>
    <description>In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.</description>
    <arm_group_label>0.9% saline</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>plasmalyte</intervention_name>
    <description>In each group, patients received either 0.9% normal saline or plasmalyte solution until end of surgery.</description>
    <arm_group_label>plasmalyte</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1.50 patients (aged 20-65) undergoing cervical or lumbar spine surgery who were diagnosed
        spinal stenosis involving more than tow spinal levels.

        Exclusion Criteria:

          1. ASA class III or IV

          2. pregnancy

          3. breast feeding

          4. lack of mental weakness(including disabled)

          5. using diuretics

          6. respiratory insufficiency

          7. metabolic acidosis or alkalosis

          8. coagulation disorder

          9. over hydtration

         10. renal failure or serum creatinine &gt; 1.4mg/dl

         11. anemia (Hemoglobin 9.0&lt;mg/dl)

         12. hypernatremia (Na &gt; 145mEq/L)

         13. Hyperkalemia (K&gt;5.5mEq/L)

         14. psychological medication or any drugs that influences renal clearance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2013</study_first_submitted>
  <study_first_submitted_qc>May 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2013</study_first_posted>
  <last_update_submitted>May 13, 2013</last_update_submitted>
  <last_update_submitted_qc>May 13, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>metabolic acidosis, plasmalyte solution, 0.9% normal saline</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Plasma-lyte 148</mesh_term>
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

